Increased biologically effective dose (BED) to the primary tumor is associated with improved survival in patients with oligometastatic NSCLC
Ahsan Farooqi, Ethan B. Ludmir, K. G. Mitchell, Mara B. Antonoff, Chad Tang, Percy Lee, Joe Y. Chang, Yasir Y. Elamin, Daniel R. Gomez, Saumil Gandhi
Topics & Concepts
MedicineUnivariate analysisPrimary tumorProportional hazards modelInternal medicineOncologyStage (stratigraphy)Lung cancerCohortRadiation therapynon-small cell lung cancer (NSCLC)Multivariate analysisCancerMetastasisA549 cellBiologyPaleontologyLung Cancer Diagnosis and TreatmentHepatocellular Carcinoma Treatment and PrognosisLung Cancer Treatments and Mutations